Veerhealth Care Ratios

Veerhealth Care Ltd Ratios

The Veerhealth Care Ltd Ratios page provides a complete fundamental analysis of Veerhealth Care Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Veerhealth Care Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Veerhealth Care Ltd (NSE: NIYATILEAS, BSE: 511523) is currently trading at ₹20.23, with a market capitalization of ₹404.57M. As a major player in the Health technology sector and Pharmaceuticals: other industry, Veerhealth Care Ltd remains a key stock for fundamental analysis using Veerhealth Care Ltd Ratios.

Veerhealth Care Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Veerhealth Care Ltd P/E ratio currently stands at 62.54, making it one of the most tracked metrics in Veerhealth Care Ltd Ratios.

Historically, the Veerhealth Care Ltd P/E ratio has shown strong fluctuations:

• 2024: 62.54
• 2023: 102.17
• 2022: 12.67
• 2021: 0
• 2020: 13.90

The decline in Veerhealth Care Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Veerhealth Care Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.10.

Historical P/B trend:

• 2024: 1.10
• 2023: 1.90
• 2022: 0.94
• 2021: 0.57

Veerhealth Care Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Veerhealth Care Ltd P/S ratio currently stands at 1.47, an important part of Veerhealth Care Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 1.47
• 2023: 3.14
• 2022: 1.51
• 2021: 0.82

A stable or declining Veerhealth Care Ltd P/S ratio indicates cautious market sentiment.

Veerhealth Care Ltd Price to Cash Flow Ratio (P/CF)

The Veerhealth Care Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Veerhealth Care Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 13.25
• 2022: 0
• 2021: 3.57
• 2020: 4.42

The declining Veerhealth Care Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Veerhealth Care Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Veerhealth Care Ltd EV currently stands at ₹282.23M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 282.23M
• 2023: 412.58M
• 2022: 164.36M
• 2021: 75.22M

Veerhealth Care Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Veerhealth Care Ltd EV/EBITDA ratio is currently 61.25, a key metric in Veerhealth Care Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 61.25
• 2023: 67.36
• 2022: 32.66
• 2021: 0

Stable Veerhealth Care Ltd EV/EBITDA indicates balanced valuation.

Veerhealth Care Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Veerhealth Care Ltd D/E ratio is currently 0.22, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.22
• 2023: 0
• 2022: 0
• 2021: 0

Veerhealth Care Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Veerhealth Care Ltd ROE currently stands at 1.78%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 1.78
• 2023: 1.88
• 2022: 8.94
• 2021: -0.53

Declining ROE indicates pressure on profitability.

Veerhealth Care Ltd Ratios Analysis Summary

The Veerhealth Care Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Veerhealth Care Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Veerhealth Care Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.